首頁 > 市場調查報告書 > 材料/化學品

玻璃

市場調查報告書

商品編碼

1739641

全球藥用管瓶市場：市場規模（按數量、分銷類型、瓶蓋尺寸和地區分類）、未來預測

Global Pharmaceuticals Glass Vials Market Size By Capacity, By Mode of Distribution, By Cap Size, By Geographic Scope And Forecast

出版日期: 2025年05月12日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

藥用管瓶的市場規模及預測

2024 年藥用管瓶市場規模價值 148.2 億美元，預計到 2032 年將達到 216.3 億美元，2026 年至 2032 年的複合年成長率為 6.94%。

藥用管瓶是用來儲存和保護液體藥物、疫苗和其他醫療產品的小型圓柱形容器。管瓶採用優質耐化學腐蝕玻璃製成，可確保內容物的穩定性和完整性。它們設計為使用橡膠塞或金屬蓋密封，以保持無菌並防止污染。

藥用玻璃瓶用於安全、無菌地儲存藥品、疫苗和有機物質。它們能夠有效阻隔感染、光線和濕氣，確保內容物的穩定性和有效性。由於玻璃瓶能夠保持精密連接的完整性，因此常用於注射劑、口服液和診斷劑。

隨著藥物傳輸和包裝技術的進步，藥用管瓶的應用預計將持續擴展。玻璃瓶將繼續成為注射藥物（包括生技藥品和疫苗）安全儲存和給藥的關鍵。玻璃配方和管瓶設計的創新將提高耐用性和安全性，降低污染風險，並支持新型藥物療法的開發。

全球藥用管瓶市場動態

影響全球藥用管瓶市場的關鍵市場動態是：

關鍵市場促進因素

生技藥品和疫苗的成長：生技藥品和疫苗的不斷發展和商業化，極大地推動了對藥用管瓶的需求。這些產品通常需要無菌且安全的包裝，以保持其效力和穩定性。管瓶因其能夠提供惰性保護性環境，防止化學反應和污染而受到青睞。

慢性病發生率上升：全球範圍內，糖尿病、癌症和心血管疾病等慢性病的發生率上升，推動了對注射藥物和生技藥品的需求。這些治療通常需要精確、無菌的包裝解決方案，以確保安全性和有效性。管瓶是包裝這些藥物的必備材料，因為它們可以保持精細化合物的完整性。

管瓶的技術進步：管瓶製造技術的創新是市場的主要促進因素。防篡改功能、防碎玻璃配方以及滅菌技術的改進等進步，使管瓶更加安全、耐用且功能更強大。

主要挑戰

污染和破損風險：藥用管瓶易受污染和破損，這可能會損害其所含藥品的無菌性和安全性。玻璃顆粒可能會進入藥物並引起副作用。確保管瓶無缺陷並在生產過程中進行嚴格的品管至關重要。此外，必須嚴格控制搬運和儲存方法，以防止物理損壞。

製造和材料成本：生產藥用管瓶成本高昂，因為需要高品質的玻璃材料和先進的製造技術，而且由於需要專門的設備來確保管瓶尺寸精確一致以及嚴格的滅菌程序，成本進一步增加。

法規合規性和標準：藥用玻璃瓶必須遵守嚴格的法規要求和行業標準，以確保安全性、有效性和品質。遵守FDA和EMA等國際法規需要不斷更新和修改，以跟上不斷發展的標準。這要求製造商在法規業務方面投入資金，進行廣泛的測試，並準備好文件以證明其合規性。

主要趨勢：

玻璃配方和技術進步：全球藥用玻璃瓶市場在玻璃製造和技術方面取得了長足的進展。新型GLA（例如I型硼硼矽酸玻璃）具有更高的耐熱性和耐化學反應性，這對於易損藥品和生物製藥的保存至關重要。玻璃蓋技術的創新提高了化學穩定性，降低了藥物殘留和相互作用的風險。

生技藥品和個人化醫療的成長：生技藥品和個人化醫療的興起是影響藥用玻璃瓶市場的一大趨勢。疫苗、單株抗體和基因療法等生技藥品需要無菌、高品質的包裝解決方案來維持其功效和安全性。管瓶因其惰性和良好的抗污染性能而成為這些應用的首選。

永續性與環保考量：在日益嚴格的環境法規和企業責任計劃的推動下，永續性已成為藥用管瓶市場的關鍵趨勢。該產業正在探索減少玻璃塑膠生產和處置對環境影響的方法，包括實施回收計畫和採用環保的生產流程。

肖特股份公司（德國）
日本硝子株式會社（日本）
Bharat Parenterals Limited（印度）
Gerresheimer AG（德國）
SGD Pharma（瑞士）
碧迪公司（BD）（美國）
肖特股份公司（德國）
AptarGroup, Inc.（美國）
Ompi有限公司（瑞士）
中性玻璃集團（中國）

第11章市場展望與機會

新興技術
未來市場趨勢
投資機會

第12章附錄

簡稱列表
來源和參考文獻

簡介目錄

Product Code: 62079

Pharmaceuticals Glass Vials Market Size and Forecast

Pharmaceuticals Glass Vials Market Size was valued at USD 14.82 Billion in 2024 and is projected to reach USD 21.63 Billion by 2032, growing at a CAGR of 6.94% from 2026 to 2032.

Pharmaceutical glass vials are small, typically cylindrical containers used to store and protect liquid medications, vaccines, and other pharmaceutical products. Made from high-quality, chemically resistant glass, these vials ensure the stability and integrity of the contents. They are designed to be sealed with rubber stoppers and metal caps to maintain sterility and prevent contamination.

Pharmaceutical glass bottles are used for the safe and sterile storage of medicines, vaccines, and organic substances. They offer a barrier against infection, light, and humidity, thus guaranteeing the stability and effectiveness of the content. Glass bottles are often used for injectable medicines, oral liquids, and diagnostic reagents and the ability to maintain the integrity of sensitive connections.

The future use of glass vials for pharmaceuticals is expected to grow with advances in drug delivery and packaging technologies. They will continue to be essential for the safe storage and administration of injectable drugs including biologics and vaccines. Innovations in glass formulations and vial design will improve durability and safety, reduce contamination risks, and support the development of new drug therapies.

Global Pharmaceuticals Glass Vials Market Dynamics

The key market dynamics that are shaping the global Pharmaceuticals Glass Vials Market include:

Key Market Drivers:

Growth in Biologics and Vaccines: The increasing development and commercialization of biologics and vaccines is significantly driving the demand for glass vials for pharmaceutical products. These products often require sterile and secure packaging to maintain their potency and stability. Glass vials are preferred for their ability to provide an inert and protective environment preventing chemical interactions and contamination.

Rising Incidences of Chronic Diseases: The global rise in chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the demand for injectable drugs and biologics. These treatments often require precise and sterile packaging solutions to ensure their safety and efficacy. Glass vials are essential for packaging these medications as they can preserve the integrity of the delicate compounds.

Advancements in Glass Vial Technology: Innovations in glass vial manufacturing technology are a key driver of the market. Advancements such as the development of tamper-evident features, shatter-resistant glass formulations, and improved sterilization techniques are improving the safety, durability, and functionality of glass vials.

Key Challenges:

Risk of Contamination and Breakage: Pharmaceutical glass vials are susceptible to contamination and breakage which can compromise the sterility and safety of the medications they contain. Glass particles can potentially mix with the drug leading to adverse reactions. Ensuring that vials are free from defects and maintaining strict quality control during production is crucial. Additionally, handling and storage practices must be meticulously managed to prevent physical damage.

Cost of Production and Material: Producing pharmaceutical glass vials requires high-quality glass materials and advanced manufacturing techniques which can be costly. Expenses are further compounded by the need for specialized equipment to ensure accurate and consistent vial dimensions as well as rigorous sterilization procedures.

Regulatory Compliance and Standards: Pharmaceutical glass vials must adhere to stringent regulatory requirements and industry standards to ensure safety, efficacy, and quality. Compliance with international regulations such as those set by the FDA and EMA involves continuous updates and modifications to meet evolving standards. This requires manufacturers to invest in regulatory affairs, conduct extensive testing, and maintain documentation to demonstrate compliance.

Key Trends:

Advancements in Glass Formulation and Technology: The global glass bottle market in pharmaceutical products has considerable progress in glass manufacturing and technology. The new types of GLA such as type I borosilicate glass offer improved resistance to heat and chemical reactions which is of crucial importance for the storage of sensitive drugs and biologicals. Innovations in glass-covering technologies improve chemical stability and reduce the risk of leaving or interacting with drugs.

Growth in Biologics and Personalized Medicine: The increasing prevalence of biologics and personalized medicine is a key trend influencing the Pharmaceuticals Glass Vials Market . Biologics including vaccines, monoclonal antibodies, and gene therapies require sterile and high-quality packaging solutions to maintain efficacy and safety. Glass vials are preferred for these applications due to their inert nature and ability to protect against contamination.

Sustainability and Environmental Concerns: Sustainability has become an important trend in the market for glass bottles in pharmaceuticals which is due to rising environmental regulations and initiatives for corporate responsibility. The industry examines paths to reduce the environmental impact of glass plastic production and disposal, e.g. the implementation of recycling programs and the use of environmentally friendly manufacturing processes.

Global Pharmaceuticals Glass Vials Market Regional Analysis

Here is a more detailed regional analysis of the global Pharmaceuticals Glass Vials Market :

North America:

North America is the most dominant region in the pharmaceutical glass vials market. This dominance is primarily due to the presence of a well-established pharmaceutical industry and significant investments in research and development. The United States and Canada are home to numerous major pharmaceutical companies and contract manufacturing organizations that require high-quality glass vials for their pharmaceutical products including biologics and vaccines.

Additionally, North America's focus on innovation and growth in personalized medicine and biologics has intensified the need for specialized glass vials that can meet the unique requirements of these complex pharmaceutical formulations. The region's strong infrastructure including state-of-the-art manufacturing facilities and robust distribution networks supports its leading position in the global market.

Asia Pacific:

Asia Pacific is the fastest-growing region in the global pharmaceutical glass vials market. This growth is driven by rapid industrialization, increasing investments in healthcare infrastructure, and rising demand for pharmaceuticals and biologics. Countries such as China and India are expanding their pharmaceutical manufacturing capacity and increasing their production of injectable drugs, thereby significantly increasing the demand for glass vials.

Additionally, increasing local production of vaccines and biologics owing to global healthcare initiatives is further increasing the need for high-quality glass vials. In addition, the Asian-Pacific space benefits from cheap production and favorable regulatory environments and attracts local and international pharmaceutical companies. The accent put by the region on the improvement of health standards and the expansion of the pharmaceutical sector creates a robust market for glass bottles.

Pharmaceuticals Glass Vials Market: Segmentation Analysis

The Global pharmaceutical glass vials market is segmented based on Capacity, Mode of Distribution, Cap Size, and Geography.

Pharmaceuticals Glass Vials Market, By Capacity

Small Volume Vials (less than 5ml)
Big Volume Vials (5 ml or more)

Based on the Capacity, the Global Pharmaceuticals Glass Vials Market are bifurcated into Small Volume Vials, and Big Volume Vials. In the global Pharmaceuticals Glass Vials Market , small-volume vials are more dominant in the Pharmaceuticals Glass Vials Market . This dominance is driven by their widespread use in storing and administering high-value, potent medications, such as vaccines and biologics which often require precise, small doses. Their compact size makes them ideal for single-use or multi-dose applications ensuring accurate dosage and minimizing waste.

Pharmaceuticals Glass Vials Market, By Mode of Distribution

Direct Sales,
Distributors,
Online Marketplaces

Based on the Mode of Distribution, the global Pharmaceuticals Glass Vials Market is bifurcated into Direct Sales, Distributors, and Online Marketplaces. In the global pharmaceutical glass vials market, direct sales are more dominant in the pharmaceutical glass vials market due to the need for specialized, high-quality packaging solutions that require close interaction between manufacturers and pharmaceutical companies. Direct sales enable manufacturers to provide tailored solutions offer technical support, and ensure compliance with stringent regulatory standards.

Pharmaceuticals Glass Vials Market, By Cap Size

13mm Vials,

20 mm Vials,

Additional Sizes

Based on the Cap-Size Type, the Global Pharmaceuticals Glass Vials Market is bifurcated into 13mm Vials, 20 mm Vials, and Additional Sizes. In the global Pharmaceuticals Glass Vials Market , 20 mm vials are more dominant in the Pharmaceuticals Glass Vials Market due to their versatility and suitability for a wide range of drug applications including larger volume injectables and biologics. Their larger capacity accommodates more complex and high-volume formulations, which are increasingly common in the pharmaceutical industry.

Pharmaceuticals Glass Vials Market, By Geography

North America
Europe
Asia Pacific
Middle East and Africa
Rest of the world

Based on Geography, the Global Pharmaceuticals Glass Vials Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the world. North America is the most dominant region in the Pharmaceuticals Glass Vials Market due to its advanced pharmaceutical industry, significant investments in research and development, and high demand for high-quality packaging solutions. The region's well-established infrastructure and stringent regulatory standards drive the need for superior glass vials to ensure drug safety and efficacy.

Key Players

The "Global Pharmaceuticals Glass Vials Market " study report will provide valuable insight with an emphasis on the global market. The major players in the market are Schott AG, Nippon Glass Ltd., Bharat Parenterals Limited, Gerresheimer AG, SGD Pharma, Becton, Dickinson and Company, SCHOTT AG, AptarGroup, Inc., Ompi Ltd., and Neutral Glass Group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Pharmaceuticals Glass Vials Market Key Developments

In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG's expertise with Corning's glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.
In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop innovation and ideas about pharmaceutical packaging by focusing on augmented reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.
In March 2023, Schott AG launched the production of FIOLAX(R)amber pharma glass in India to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.